Denali Therapeutics Inc. (DNLI) /
The profitability of Denali Therapeutics Inc. over the past 10 years
Chart Denali Therapeutics Inc.: operating income, net income, fiscal 2016–2025 Open the chart →Denali Therapeutics Inc. reported a net loss of $512.54M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $555.34M. It reported a profit in 1 of the 10 years shown, and a loss in fiscal 2016, 2017, 2018, 2019, 2021, 2022, 2023, 2024 and 2025. Its highest net income in these years was $71.14M, in fiscal 2020.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$555.34M | -$512.54M |
| 2024ended Dec 31, 2024 | -$487.34M | -$422.77M |
| 2023ended Dec 31, 2023 | -$196.7M | -$145.22M |
| 2022ended Dec 31, 2022 | -$340.74M | -$325.99M |
| 2021ended Dec 31, 2021 | -$295.75M | -$290.58M |
| 2020ended Dec 31, 2020 | $62.72M | $71.14M |
| 2019ended Dec 31, 2019 | -$213.18M | -$197.61M |
| 2018ended Dec 31, 2018 | -$46.37M | -$36.24M |
| 2017ended Dec 31, 2017 | -$90.14M | -$88.19M |
| 2016ended Dec 31, 2016 | -$87.43M | -$86.65M |
Fiscal years as Denali Therapeutics Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Denali Therapeutics Inc.
- The revenue of Denali Therapeutics Inc.
- The cash flow of Denali Therapeutics Inc.
- The debt of Denali Therapeutics Inc.
- All of Denali Therapeutics Inc.'s financials, charted
Companies of a similar size
- STEPSTEPSTONE GROUP INC.
- GNWGENWORTH FINANCIAL, INC.
- TNKTEEKAY TANKERS LTD.
- COCOThe Vita Coco Company, Inc.
- LMNDLemonade, Inc.
Not investment advice. This page shows what Denali Therapeutics Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.